Semin Thromb Hemost 1996; 22(5): 393-398
DOI: 10.1055/s-2007-999037
Copyright © 1996 by Thieme Medical Publishers, Inc.

Gene Defects in Congenital Factor XIII Deficiency

Hanna Mikkola, Aarno Palotie
  • From the Department of Clinical Chemistry and the Laboratory Department of Helsinki University Central Hospital, Helsinki, Finland.
Further Information

Publication History

Publication Date:
08 February 2008 (online)

Abstract

The knowledge of the molecular basis of factor XIII deficiency has improved significantly in recent years. Almost 20 different mutations have been described in the gene coding for the factor A-subunit and 3 mutations in the gene coding for the B-subunit. Half of the mutations in the factor XIIIa A-subunit gene are nonsense mutations that result in premature termination of translation. Three of them are frameshift mutations that are caused by minor deletions. Two of them are splicing mutations and 3 are stop mutations that are caused by single nucleotide substitutions. Ten of the mutations are missense mutations caused by nucleotide transitions leading to amino acid substitutions. In the factor XIII B-subunit gene, the 3 mutations are an amino acid substitution, a splicing mutation, and a trinucleotide insertion. These mutations explain the disease in the two families reported to have XIII B-subunit deficiency. In factor XIII A-subunit deficiency, the genetic defects have been characterized so far only in a minority of cases. In most of the reports of factor XIII A-subunit mutations, each family carries its own mutation/mutations. However, in some populations such as Finns and Arabs some enrichment of specific mutations has occured. Some international migration of a few mutations has also been noted. The structural and functional effects of the mutations have been analyzed by studying the expression of the factor XIII subunits on mRNA and protein levels in vivo or in vitro, and by utilizing the threedimensional model of crystallized factor XIII A-subunit in modeling of the missense mutations.